Frontage Holdings Corp., a CRO with a presence in both the U.S. and China, through 11736655 CANADA LTD., a subsidiary of the group, and Frontage Laboratories, Inc., entered into a share purchase agreement with J&J Corporate Services, Inc., an independent third party. According to the agreement, 11736655 CANADA LTD. will purchase all of the outstanding shares of BRI Biopharmaceutical Research, Inc. (BRI) owned by J&J Corporate Services, Inc.   BRI is a CRO that was established by its cu...